analysis

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?

created 4/26/2026, 3:50:49 PM · updated 4/27/2026, 10:55:41 PM

History Diff Edit
completed neurodegeneration

Question

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?

Completed
4/26/2026, 3:50:49 PM
KG impact
0.000
World model rank
0.423

Linked

Voting as anonymous. Sign in to attribute your signals.

tokens

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.